LifeStance Health (LFST) Capital Expenditures (2020 - 2026)

LifeStance Health (LFST) has reported Capital Expenditures for 7 consecutive years, with $10.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Capital Expenditures rose 50.21% year-over-year to $10.8 million; the TTM figure through Mar 2026 stood at $39.7 million (up 68.11% YoY), while the FY2025 annual figure was $36.1 million, up 67.51% from the prior year.
• Capital Expenditures declined to $10.8 million in Q1 2026 per LFST's latest filing, from $10.9 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $27.9 million in Q1 2022 and bottomed at $5.1 million in Q3 2024.
• Historically, Capital Expenditures has averaged $11.1 million across 5 years, with a median of $10.3 million in 2025.
• On a YoY basis, Capital Expenditures climbed as much as 151.87% in 2022 and fell as far as 73.15% in 2022.
• LifeStance Health's Capital Expenditures stood at $10.4 million in 2022, then gained by 9.92% to $11.4 million in 2023, then tumbled by 44.8% to $6.3 million in 2024, then surged by 73.16% to $10.9 million in 2025, then decreased by 1.32% to $10.8 million in 2026.
• Business Quant data shows LFST's Capital Expenditures at $10.8 million in Q1 2026, $10.9 million in Q4 2025, and $10.3 million in Q3 2025.